https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
New targeted therapies have changed cancer treatment in the past decades. However, high prices of targeted anticancer medications have increased economic burden for both patients and health insurance systems. In July 2017, China implemented combined medication price negotiation and mandatory reimbursement policies for 15 targeted anticancer medications. This study assesses effects of the policy on hospital procurement prices, volumes and spending. Using a quasi-experimental interrupted time series design, we analysed p
Like
Comment
Share
